NVCR PE Ratio & Valuation,Is NVCR Overvalued

NVCR Relative Valuation

NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVCR is overvalued; if below, it's undervalued.

Historical Valuation

Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.17 is considered Undervalued compared with the five-year average of -7.07. The fair price of Novocure Ltd (NVCR) is between 14.60 to 111.62 according to relative valuation methord. Compared to the current price of 13.19 USD , Novocure Ltd is Undervalued By 9.64%.

Relative Value

Fair Zone

14.60-111.62

Current Price：13.19

9.64%

Undervalued

-8.82

-9.53

EV/EBITDA

Novocure Ltd. (NVCR) has a current EV/EBITDA of -9.53. The 5-year average EV/EBITDA is -122.81. The thresholds are as follows: Strongly Undervalued below -805.90, Undervalued between -805.90 and -464.36, Fairly Valued between 218.73 and -464.36, Overvalued between 218.73 and 560.27, and Strongly Overvalued above 560.27. The current Forward EV/EBITDA of -9.53 falls within the Historic Trend Line -Fairly Valued range.

-7.75

EV/EBIT

Novocure Ltd. (NVCR) has a current EV/EBIT of -7.75. The 5-year average EV/EBIT is -56.99. The thresholds are as follows: Strongly Undervalued below -643.96, Undervalued between -643.96 and -350.48, Fairly Valued between 236.49 and -350.48, Overvalued between 236.49 and 529.98, and Strongly Overvalued above 529.98. The current Forward EV/EBIT of -7.75 falls within the Historic Trend Line -Fairly Valued range.

2.17

Novocure Ltd. (NVCR) has a current PS of 2.17. The 5-year average PS is 11.75. The thresholds are as follows: Strongly Undervalued below -8.21, Undervalued between -8.21 and 1.77, Fairly Valued between 21.73 and 1.77, Overvalued between 21.73 and 31.71, and Strongly Overvalued above 31.71. The current Forward PS of 2.17 falls within the Historic Trend Line -Fairly Valued range.

-1491.60

P/OCF

Novocure Ltd. (NVCR) has a current P/OCF of -1491.60. The 5-year average P/OCF is -12.61. The thresholds are as follows: Strongly Undervalued below -1132.15, Undervalued between -1132.15 and -572.38, Fairly Valued between 547.17 and -572.38, Overvalued between 547.17 and 1106.94, and Strongly Overvalued above 1106.94. The current Forward P/OCF of -1491.60 falls within the Strongly Undervalued range.

-31.65

P/FCF

Novocure Ltd. (NVCR) has a current P/FCF of -31.65. The 5-year average P/FCF is 104.90. The thresholds are as follows: Strongly Undervalued below -284.53, Undervalued between -284.53 and -89.82, Fairly Valued between 299.62 and -89.82, Overvalued between 299.62 and 494.33, and Strongly Overvalued above 494.33. The current Forward P/FCF of -31.65 falls within the Historic Trend Line -Fairly Valued range.

Novocure Ltd (NVCR) has a current Price-to-Book (P/B) ratio of 4.37. Compared to its 3-year average P/B ratio of 7.44 , the current P/B ratio is approximately -41.21% higher. Relative to its 5-year average P/B ratio of 16.15, the current P/B ratio is about -72.93% higher. Novocure Ltd (NVCR) has a Forward Free Cash Flow (FCF) yield of approximately -4.37%. Compared to its 3-year average FCF yield of -3.89%, the current FCF yield is approximately 12.43% lower. Relative to its 5-year average FCF yield of -2.09% , the current FCF yield is about 109.42% lower.

4.26

P/B

Median3y

7.44

Median5y

16.15

-4.37

FCF Yield

Median3y

-3.89

Median5y

-2.09

Competitors Valuation Multiple

The average P/S ratio for NVCR's competitors is , providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 7.81%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of NVCR decreased by 56.48% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -19.71 to -22.29.

The secondary factor is the Revenue Growth, contributed 7.81%to the performance.

Overall, the performance of NVCR in the past 1 year is driven by Margin Expansion. Which is more sustainable.

7.81%

155.10M → 167.20M

Revenue Growth

13.09%

-19.71 → -22.29

Margin Expansion

-77.38%

-35.70 → -8.08

P/E Change

-56.48%

29.80 → 12.97

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Novocure Ltd (NVCR) currently overvalued or undervalued?

What is Novocure Ltd (NVCR) fair value?

NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Novocure Ltd (NVCR) is between 14.60 to 111.62 according to relative valuation methord.

How does NVCR's valuation metrics compare to the industry average?

What is the current P/B ratio for Novocure Ltd (NVCR) as of Dec 16 2025?

As of Dec 16 2025, Novocure Ltd (NVCR) has a P/B ratio of 4.37. This indicates that the market values NVCR at 4.37 times its book value.

What is the current FCF Yield for Novocure Ltd (NVCR) as of Dec 16 2025?

As of Dec 16 2025, Novocure Ltd (NVCR) has a FCF Yield of -4.37%. This means that for every dollar of Novocure Ltd’s market capitalization, the company generates -4.37 cents in free cash flow.

What is the current Forward P/E ratio for Novocure Ltd (NVCR) as of Dec 16 2025?

As of Dec 16 2025, Novocure Ltd (NVCR) has a Forward P/E ratio of -9.06. This means the market is willing to pay $-9.06 for every dollar of Novocure Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Novocure Ltd (NVCR) as of Dec 16 2025?

As of Dec 16 2025, Novocure Ltd (NVCR) has a Forward P/S ratio of 2.17. This means the market is valuing NVCR at $2.17 for every dollar of expected revenue over the next 12 months.

NVCR Valuation